This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
As researchers around the world race to develop a safe and effective COVID-19 vaccine, pharma companies also face another daunting challenge: how to distribute hundreds of millions of highly sensitive vaccine doses, quickly and accurately, across the country and the world.
While the human aspect of this outbreak is clearly the biggest story, the virus is causing major disruptions in global supplychains as well. As my colleague Steve Banker pointed out yesterday, the global high-tech supplychain has been hit particularly hard. But other industries are feeling the impact as well.
The global manufacturing and distribution of pharmaceuticals and the regulatory requirements of countries have always made pharmaceuticalsupplychains a challenge. Read more Five Technological Advances that Will Transform PharmaceuticalSupplyChain Visibility.
Pharmaceutical companies run two types of supplychains. There is the commercial supplychain where drugs that have been approved for use on patients are shipped to distributors, drug stores, and hospitals around the world. Then there is a clinical trials supplychain. dollars on drug development.
Gaining a higher level of visibility into pharmaceuticalsupplychains is essential as the portion of pharmaceutical products sensitive to temperature, vibration, humidity or timing is growing at approximately twice the rate of non-cold chain products. Gaps in pharma critical cold chain.
Joel Wayment and Joe Lynch discuss the biopharma supplychain. Joel is the Vice President of Operations at Cardinal Health Third Party Logistics, a leader in healthcare logistics for over four decades and a 3PL pioneer since 1995, streamlines pharmaceutical delivery, mitigating risk and fostering seamless patient journeys.
One in the pharmaceuticals industry and another in consumer hi-tech products. These are numbers that aren’t unusual anymore – both high-tech consumer products and pharma are seeing major changes to different product categories. Subscribe to our SupplyChain Digest to get notified when it’s live.
Undetected in-transit issues in the cold chain can cost companies billions of dollars in lost revenue. Data collection is no new concept for the pharmaceuticalsupplychain –– but is it the right data? The compliance standards that pharmasupplychain visibility solutions need to meet.
However, supplychain leaders well understand that drug discovery, manufacturing, and distribution are all necessary to deliver the vaccine to a willing arm. Development and distribution, as any supplychain leader knows, are two different topics. As a result, the supplychain, as we knew it is dead.
The post 3 New Innovations Set to Enhance the Cold Chain, Reduce Health Risks, and Cut PharmaceuticalSupplyChain Costs appeared first on The Network Effect.
The pharmaceutical industry is growing exponentially, and products that are sensitive to temperature, vibration, humidity, and/or timing are growing at twice the rate of non-cold chain products. Improving visibility in these supplychains is essential. Gaps in pharma critical cold chain.
Alex is the Director of Sales, Life Science and Pharma Europe at Tive , the leading provider of real-time supplychain visibility insights that help logistics professionals actively manage their in-transit shipments’ location and condition. Clinical pharmaceuticals. Medical cold chain. About Alex Guillen.
And how can supplychain planning help? In one project, I am interviewing over fifty supplychain leaders on their perceived impact of advanced planning, what makes a good plan, and how effectively they use the technology. I am also writing the new edition of the SupplyChains to Admire.
When we talk about greener energy, the Pharmaceutical industry has to make crucial changes; many large pharma companies have determined carbon reduction goals, moving away from fossil fuels and greener, renewable energy resources.
Josh Allen and Joe Lynch discuss Tive’s validated, real-time visibility for pharma. Josh is CRO at Tive , a leading provider of real-time supplychain visibility insights that help logistics professionals actively manage their in-transit shipments’ location and condition. About Josh Allen . About Tive.
Medical and pharmaceutical manufacturers have faced increasing logistical challenges over the past two years. Amid significant regulatory and compliance changes around the world, they've had to contend with massive supplychain disruptions caused by the pandemic.
A few years ago, I interviewed Tony Martins, former VP Strategic Services at Halo Pharmaceutical. Read more Making a Difference: SupplyChains for a Better Tomorrow. Read more Making a Difference: SupplyChains for a Better Tomorrow.
Wikipedia Unleashing the Contrarian Here are my thoughts this morning over coffee: Gartner Top 25: Really A Celebration of SupplyChain Leadership? Designed to lift the profession and celebrate supplychain results, I struggle to find that the methodology supports either objective.
Today, we published The SupplyChains to Admire for 2023. Nvidia, Northrup Grumman, PACCAR Inc, PCA (Packaging Corporation of America), ResMed, Rockwell Automation, Ross Stores, Taiwan Semiconductor Manufacturing (TSMC) Company, Tempur-Pedic, TJX, Toro, Toyota, West Pharma, United Tractors, and Urban Outfitters. I admit it.
by Dr. Madhav Durbha The 2017 Gartner supplychain executive conference took place at the O2-Intercontinental Hotel in London on September 20 th and 21 st. The theme of the conference was ACT (Aspire, Challenge, Transform), same as the Gartner supplychain summit in Phoenix during May of this year. Collaborative.
There’s little room for error in most global supplychains, but none for the pharma cold chain. In this article, produced in partnership with Connected Health Pulse, we explore five critical challenges in pharmaceuticalsupplychains caused by a lack of visibility.
He shared that he worked for a freight forwarder providing supplychain planning services for a major retailer. Most supplychain leaders focus on cost reduction and are unclear on value-based outcomes. I feel that supplychain processes are analogous. The Efficient SupplyChain Is The Most Effective.
by Bill DuBois The life sciences supplychain starts with a miracle. In a recent Forbes interview on why it’s so hard to bring tech into pharma, Vas Narasimhan, Chief Executive Officer of Novartis AG pointed out that only one in twenty drugs make it out of clinical trials. Is there a more challenging industry than life sciences?
by CJ Wehlage The SupplyChain Insights annual conference was held on September 10-11, 2014 at the Phoenician in Scottsdale, Arizona. Great memories here, as so much has changed in the supplychain research world these past 5+ years. All ex-AMR analysts on the stage, talking about the ‘Top 15 SupplyChains we Admire’.
Supplychain sustainability is a higher priority than ever. In MIT’s State of SupplyChain Sustainability 2021 , 80% of executives surveyed said the pandemic either had no impact on their commitment or increased it. We must plan, source, make, and deliver differently for supplychain sustainability.
Kearney research shows that the more companies invest, the bigger the average ROI Investments in supplychain firms and technologies represent 15-20% of total venture capital investments, according to a recent report by the management consulting firm Kearney. More than 150 supplychain startups have been acquired in the last two years.
By Shyam Krishna, (pictured) Vice President of Healthcare Solutions, Softeon The post Get Ready, Pharma: Drug SupplyChain Security Act (DSCSA) Enforcement Is At Hand appeared first on IT SupplyChain.
states, obvious disruptions to supplychains and supplychain risk management were a given. Many of the states affected contained key ports and supply destinations, as well as transportation and logistics hubs. The human links of the supplychain were stressed. These ports accounted for 18.3%
This is a story for the Eds, Franks, and Toms working together in supplychains across the globe. It is also a story for a young supplychain manager attempting to make a difference, but feeling stymied. Efficient supplychains may not be the most effective. Need for SupplyChain Leadership.
Factories for most commodities (other than essential commodities, pharma, medicinal and medical devices, food and groceries) were shutdown globally. Huge demand supply issues breaking the ever-so-fragile supplychain globally. It is now or never for supplychains globally if they do not put their acts together!
Supplychain resiliency and sustainability are top priorities for CEOs today. To achieve these goals, corporate leadership must focus on two key areas: shift from internally focused supplychains to collaborative supply networks and actively design their supplychains.
Megatrends Shaping SupplyChain Innovation. While the COVID-19 pandemic woke up supplychains around the world, the ripple effects continue to disrupt in both size and scope. How are supplychains planning for further disruption and uncertainty? Creating a more resilient supplychain.
Subscribe to SupplyChain Game Changer. How Cold Chain Differs Between the Food and Pharmaceutical Industries! An increased level of competition characterizes the pharmaceutical market. Today, software development is an effective marketing tool in the pharmaceutical market. Email Address.
As I was enjoying the holidays, I had an opportunity to reflect on the year past and what the future holds for supplychains. However, organizations will need to be deliberate in designing supplychains with optionality so it does not become cost prohibitive. SupplyChain Design is essential in tackling these.
In supplychain management, it is widely accepted that holding enough finished goods inventory to fulfill every order is just too costly. Ipsen, a global bio-pharmaceutical company , disproves that. The post Does Perfect Customer Service Make Sense? appeared first on Logistics Viewpoints.
That’s the question that continues to bedevil the global supplychain industry. As I detailed in a recent column , the answer to constant supplychain volatility is pervasive real-time visibility into the precise location, temperature or status of a shipment — at any point along the journey. Where’s my shipment? .
Jim Saponaro and Joe Lynch discuss the life sciences and healthcare supplychain. Jim is the President, Life Sciences & Healthcare DHL SupplyChain North America. About Jim Saponaro Jim Saponaro is the President, Life Sciences & Healthcare DHL SupplyChain North America. ft in warehousing space.
For businesses, DPPs are becoming essential to comply with best practice guidance as well as coming statutory regulations that demand transparency in supplychains. Blockchain can also build trust in the supplychain, as all channel stakeholders can verify the same data.
According to one survey , only 27% of leaders believe that they have the talent needed to meet current supplychain performance requirements. What should supplychain leaders be looking for to close the talent gap? AGCO Logistics Team Accepts Prestigious SupplyChain Award. We need people that are adaptable.
We organize all of the trending information in your field so you don't have to. Join 102,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content